SVA:CA Stock

Research Capital analyst Andre Uddin says Sernova Biotherapeutics’ (Sernova Biotherapeutics Stock ... Read More

Research Capital analyst Andre Uddin maintained a “Speculative Buy” rating and C$0.60 price targ... Read More

Its most recent quarterly results are in the books, but Research Capital analyst Andre Uddin is look... Read More

SERNOVA Following the release of new data on a core offering, Research Capital analyst Andre Uddin r... Read More

Following the release of new data on a core offering, Research Capital analyst Andre Uddin remains u... Read More